Milatuzumab doxorubicin | Interleukin Related interleukin-related.com

Product Name :
Milatuzumab doxorubicin

Search keywords :
Milatuzumab

drugId :
null

Target Vo:
Topoisomerase II

Target Vo Short Name :
TOP2

Moa_Name:
DNA intercalators

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Immunomedics Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Multiple Myeloma

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
IKK alpha Antibody
Phospho-CDK1/2/3 (Thr14) Antibody
CD166 Antibody: CD166 Antibody is an unconjugated, approximately 62 kDa, rabbit-derived, anti-CD166 polyclonal antibody. CD166 Antibody can be used for: WB, ELISA, IHC-F, Flow-Cyt, IF expriments in human, and predicted: mouse, rat, chicken, dog, pig, cow, horse, rabbit background without labeling.

Author: Interleukin Related

Related Posts